Rapport Therapeutics, Inc. RAPP Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$19.86M+17.5% | -$33.76M-69.0% | -$26.93M-53.5% | -$26.73M-47.5% | -$24.06M-6.1% | ||
| $227K-7.0% | $265K+1.9% | $256K+16.9% | $252K+21.2% | $244K+60.5% | ||
| $6.96M+72.4% | $5.69M+77.4% | $4.74M+48.8% | $4.39M+86.4% | $4.04M+171% | ||
| -$13.06M+35.5% | -$24.7M-71.0% | -$17.47M-6.4% | -$25.07M-53.3% | -$20.24M-14.9% | ||
| $86K-70.4% | $169K-25.2% | $134K-4.3% | $22K-97.7% | $291K-72.9% | ||
| $37.94M+80.4% | -$174.32M— | -$56.78M-7.0% | $22.6M+121% | $21.03M+150% | ||
| $531K+10,520% | $311K+4,343% | $270.53M— | -$63K-100% | $5K-100.0% | ||
| $25.41M+3,080% | -$198.71M— | $196.29M+377% | -$2.54M-107% | $799K-80.6% | ||
| -$13.15M+36.0% | -$24.87M-69.5% | -$17.6M-6.3% | -$25.09M-44.9% | -$20.53M-9.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rapport Therapeutics, Inc. generate?
- Rapport Therapeutics, Inc. (RAPP) generated -$80.3M in operating cash flow over the trailing twelve months.
- What is Rapport Therapeutics, Inc.'s free cash flow?
- After $411.0K of capital expenditures, Rapport Therapeutics, Inc.'s free cash flow was -$80.7M over the trailing twelve months, down 16.8% year over year.
- Where does Rapport Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Rapport Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.